Drug intelligence / Profile preview

pigment epithelium-derived factor

Development stage
Unknown
Lead developer
National Eye Institute
Modality
Recombinant Proteins and Enzymes, Gene Therapies
Administration
Intravitreal, Subretinal, Intravenous, Topical
01

Overview

Pigment epithelium-derived factor (PEDF) is a multifunctional 50 kDa secreted glycoprotein belonging to the serine protease inhibitor (serpin) superfamily. Despite its classification as a serpin, it does not exhibit protease inhibitory activity. Instead, PEDF is recognized as one of the most potent endogenous inhibitors of angiogenesis, primarily acting by antagonizing the effects of vascular endothelial growth factor (VEGF) and inducing apoptosis in remodeling endothelial cells. Beyond its anti-angiogenic properties, PEDF provides significant neuroprotection to photoreceptors and motor neurons, exhibits anti-inflammatory effects, and demonstrates anti-tumorigenic activity across various malignancies. Therapeutic development of PEDF includes recombinant protein delivery and gene therapy approaches (using adenoviral or adeno-associated viral vectors) for conditions such as age-related macular degeneration (AMD), diabetic retinopathy, and various cancers.

Other names
PEDFserpin F1cell proliferation-inducing gene 35 proteinearly population doubling level cDNA-1
02

Targets

COL1 (Collagen type I)Heparan sulfate proteoglycan-collagen type I interaction site

Beyond the preview

Go deeper on pigment epithelium-derived factor.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on pigment epithelium-derived factor.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call